ArticleMicromachines2025
Lead-Free Potassium Sodium Niobate-Based Wearable Ultrasonic Patches for Blood Pressure Detection.
Article in Micromachines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Wearable ultrasound: a review of core technologies and clinical applications in cardiovascular monitoring.Microsystems & nanoengineering · 2026Review
- Advances and Prospects of Wearable Ultrasound Devices.Micromachines · 2026Article
- Ultrasound Patches Toward Intelligent Theranostics: From Flexible Materials to Closed-Loop Biomedical Systems.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Ultrasound is one of the most promising methods for blood pressure monitoring due to its harmless, non-invasive, and high-precision characteristics. To further enhance the biocompatibility of ultrasound blood pressure monitors, this work reports wearable ultrasonic patches for blood pressure monitoring based on lead-free KNN (potassium sodium niobate)-based materials. The patches are designed and fabricated with a center frequency of 5 MHz and dimensions of 2.8 mm × 2.8 mm, optimized for both electrical impedance matching and vascular detection. Moreover, biocompatible silicone rubber is used for the packaging. The wearable ultrasonic patches are demonstrated to effectively transmit and receive signals. The diameter of artificial blood vessels is measured to validate the vascular diameter detection capability of the patches. The relationship between blood pressure and vascular diameter is then calculated. A radial artery vascular system platform is built to simulate changes in human blood pressure. Finally, the patches are shown to successfully measure the variation in vessel diameters on this platform. These patches exhibit sufficient detection ability, good biocompatibility, and can adhere tightly to human skin without coupling agents, providing the possibility for safe, sustainable, comfortable, and wearable long-term blood pressure monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.